09 Nov Unraveling tumor-immunosuppressive mechanisms to abrogate intravenous BCG efficacy in a metastatic lung adenocarcinoma mouse model.

Posted at 01:33h in Precision immunotherapy by

ID: 2606

Autores: Guerrero Perales, Claudia  (0); Guerrero, Claudia (1,2); Moreo, Eduardo (1,2); Uranga, Santiago (1,2); Gomez, Ana Belen (1,2); Martin, Carlos (1,2); Aguiló, Nacho (1,2)

Temática: Precision immunotherapy

Etiquetas: